Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance

Proceedings of the National Academy of Sciences of the United States of America

Rosalynd Upton, Allison Banuelos, Dongdong Feng, …, Jens-Peter Volkmer, Mark D Pegram, Irving L Weissman

• DOI: 10.1073/pnas.2026849118
• PMID: 34257155
• PMCID: PMC8307693